Open Access
Numéro
Ann Toxicol Anal
Volume 21, Numéro 4, 2009
Page(s) 197 - 202
DOI https://doi.org/10.1051/ata/2009058
Publié en ligne 17 décembre 2009
  1. Tunbridge R. Conclusions and recommendations of the seminar Pompidou Group. In: Road Traffic and Psychoactive Substances. Strasbourg: Council of Europe Publishing 2004: 377–378.
  2. Krüger HP, Bud Perrine MW, Mettke M, Huessy FB. Illicit drugs in road traffic. Overview of the legal provisions, difficulties faced by police, and analysis of prevention attempts in selected European countries, P-PG/Circrout (98) 4 rev. Council of Europe, Pompidou Group. Strasbourg: 1999: 1–29.
  3. Verstraete A. Oral fluid testing for driving under the influence of drugs. History, recent progress and remaining challenges. Forensic Sci Int. 2005; 150(2-3): 143–150. [CrossRef] [PubMed]
  4. Maes V, Charlier C, Grenez O, Verstaete A. Drugs and medicines that are suspected to have a detrimental impact on road user performance, in: Verstraete A (Project coordinator), ROSITA: Roadside Testing Assessment, Ghent University, Ghent, Belgium 2000: 5–44 (ROSITA Contract No. DGVII PL 98-3032).
  5. Höld M, de Boer D, Zuidema J, Maes R. Saliva as an analytical tool in toxicology. Int J Drug Testing. 1996; 1: 1–36.
  6. Mandel ID. The diagnosis use of saliva. J Oral Pathol Med. 1990; 19: 119–125. [CrossRef] [PubMed]
  7. Gorodischer R, Koren G. Salivary excretion of drugs in children: theoretical and practical issues in therapeutic drug monitoring. Dev Pharmacol Ther. 1992; 19: 161–168. [PubMed]
  8. Kaufman E, Lamster I. The diagnostic applications of saliva – a review. Crit Rev Oral Biol Med. 2002; 13: 197–202. [CrossRef] [PubMed]
  9. Haeckel R. Factors influencing the saliva/plasma ratio of drugs. Ann N Y Acad Sci. 1993; 694: 128–142. [CrossRef] [PubMed]
  10. Leute R, Ullman E, Golstein A. Inmunoassay of opiate narcotics in urine and saliva. J Am Med Assoc. 1972; 221: 1231–1234. [CrossRef] [PubMed]
  11. Peel H, Perrigo B, Mikhael N. Detection of drugs in saliva of impaired drivers. J Forensic Sci. 1984; 29: 185–189. [PubMed]
  12. Wals J, Flegel R, Crouch D, Cangianelli L, Baudys J. An evaluation of rapid point of collection oral fluid drugs-testing devices. J Anal Toxicol. 2003; 27(7): 429–439. [CrossRef] [PubMed]
  13. (a) Möller M, Steinmeyer S, Aberl F. Deliverable D3: Operational, user and legal requirements across EU members states for roadside drug testing equipment. In: ROSITA deliverables. Gent. ROSITA Consortium.1999; D3. (b) VerstraeteA. `Results of the Certified and Rosita projects'. In: Road traffic and psychoactive substances: basic documents, conclusions and recommendations – Report on the seminar in September 2003, p. 323, Pompidou Group, Strasbourg. (c) Verstraete A and Raes E (2006), `Rosita-2 project: final report' (available from www.rosita.org).
  14. Campora P. La espectrometría de masas por impacto electrónico e ionización química en el análisis de drogas de abuso en saliva. Tesis Doctoral 2001. Universidad de Santiago de Compostela. Facultad de Medicina. Instituto de Medicina Legal.
  15. Observatorio Español de Drogas. Informe nFormula 6. Plan nacional de Drogas. Ministerio de Sanidad 2003.
  16. Starner G, Mascord D, Tattam B, Zeleny R. Analysis for drugs in saliva. CR 141 Australian government publishing service. Canberra 1994: 1-76.
  17. Krugger HP, Shcultz E, Magerl H. The German roadside survey 1992-1994. Saliva analyses from an unselected driver population : licit and illicit drugs. In: Kloeden CN, Wada AJ, McLean A (Eds). Alcohol, Drugs and safety- T 95NHMRC Road accident research unit. Adelaide: University of Adelaide 1995: 55–62.